Biomarin Pharmaceutical Inc. Stock Performance
as on November 1, 2025 at 1:29 am IST
Day's Low
$51$53.59
4.83%
Downside
52 Week's Low
52 Week's High
$51.1$73.514.65%
Downside
37.17%
Upside
Biomarin Pharmaceutical Inc. share price movements today
- Previous Close
- $51.91
- Open
- $51.12
- Volume
- 2.2M
- Day's Low - High
- $51 - $53.59
- 52 Week Low - High
- $51.1 - $73.51
Biomarin Pharmaceutical Inc. Historical Returns
- 1 Month Return
- -5.38 %
- 3 Month Return
- -10.27 %
- 1 Year Return
- -21.22 %
- 3 Year Return
- -40.08 %
- 5 Year Return
- -30.26 %
Biomarin Pharmaceutical Inc. Stock Fundamentals & Key Indicators
Check Biomarin Pharmaceutical Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.0B
EPS (TTM)
3.5889
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
1.24%
PE Ratio (TTM)
19.28
Industry PE ratio
19.200384615384614
PEG Ratio
0.6335
EBITDA
707.0M
Revenue (TTM)
3.1B
Profit Margin
16.82%
Return On Equity TTM
9.07%
Biomarin Pharmaceutical Inc. Stock Valuation
Track how Biomarin Pharmaceutical Inc. P/E has moved over time to understand its valuation trends.
Biomarin Pharmaceutical Inc. in the last 5 years
Lowest (13.26x)
September 30, 2025
Industry (19.20x)
October 31, 2025
Today (19.28x)
October 31, 2025
Highest (181.43x)
June 30, 2023
Today’s Price to Earnings Ratio: 19.28x
Biomarin Pharmaceutical Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Biomarin Pharmaceutical Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $10.0B | -30.26% | 19.28 | 16.82% | |
| BUY | $41.1B | 489.62% | -16.34 | -259.82% | |
| BUY | $63.1B | 265.59% | -505.15 | -12.96% | |
| BUY | $107.0B | 101.52% | 29.67 | 31.86% | |
| BUY | $68.6B | 20.33% | 15.65 | 32.13% |
Stock Returns calculator for Biomarin Pharmaceutical Inc. Stock including INR - Dollar returns
The Biomarin Pharmaceutical Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biomarin Pharmaceutical Inc. investment value today
Current value as on today
₹86,974
Returns
Returns from Biomarin Pharmaceutical Inc. Stock
Dollar Returns*
₹5,642 (+5.64%)
Analyst Recommendation on Biomarin Pharmaceutical Inc. Stock
Based on 35 analysts
74.29%
Buy
25.71%
Hold
0.00%
Sell
Based on 35 analysts, 74.29% of analysts recommend a 'BUY' rating for Biomarin Pharmaceutical Inc.. Average target price of $90.88
Biomarin Pharmaceutical Inc. Share Price Target
Get share price movements and forecasts by analysts on Biomarin Pharmaceutical Inc..
What analysts predicted
41.03%UPSIDE
Target Price
$90.88
Current Price
$53.59
Analyzed by
35 Analysts
Target
$90.88
Biomarin Pharmaceutical Inc. target price $90.88, a slight upside of 41.03% compared to current price of $53.59. According to 35 analysts rating.
Biomarin Pharmaceutical Inc. Stock’s Investor Sentiment and Interest
Search interest for Biomarin Pharmaceutical Inc. Stock has increased by 54% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:54% versus previous 30 day period
Biomarin Pharmaceutical Inc. Quarterly Profit & Loss
All numbers in Millions USD
Biomarin Pharmaceutical Inc. Annual Profit & Loss
All numbers in Millions USD
Biomarin Pharmaceutical Inc. Quarterly Cash Flow
All numbers in Millions USD
Biomarin Pharmaceutical Inc. Annual Cash Flow
All numbers in Millions USD
Biomarin Pharmaceutical Inc. News & Key Events
Today's Timeline - 28 October
Tue, 11:01 AM
-BioMarin's Q3 results show 4.1% revenue growth; adjusted EPS guidance lowered by over 20%.
Tue, 06:56 PM
-RBC Capital lowers BioMarin's price target to $66, maintaining a Sector Perform rating after Q3 results.
Tue, 09:40 PM
-BioMarin shares rise 4.5% post-earnings report despite earnings miss; revenue guidance slightly increased.
Today's Timeline - 28 October
Tue, 09:54 PM
-Wells Fargo and Morgan Stanley maintain Buy ratings on BioMarin, citing growth potential and strong market position.
Tue, 11:56 PM
-BioMarin reports Q3 earnings; adjusted EPS of 12 cents beats estimates, but revenues miss expectations.
Insights on Biomarin Pharmaceutical Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Insmed Incorporated has given 1021.4% return, outperforming this stock by 1061.5%
- NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 188.7% return, outperforming this stock by 209.9%
NEGATIVE IMPACTPrice Dip
In the last 6 months, BMRN stock has moved down by -18.5%
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 825.41M → 776.13M (in $), with an average decrease of 6.0% per quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 240.53M → -30.74M (in $), with an average decrease of 112.8% per quarter
About Biomarin Pharmaceutical Inc.
| Organisation | Biomarin Pharmaceutical Inc. |
| Headquarters | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
| Industry | Health Technology |
| CEO | Mr. Alexander Hardy |
| E-voting on shares | Click here to vote |
Key Management of Biomarin Pharmaceutical Inc.
Name | Title |
|---|---|
Ms. Cristin Hubbard | Executive VP & Chief Commercial Officer |
Dr. Kevin Eggan Ph.D. | Chief Scientific Officer & Senior VP of Research and Early Development |
Ms. Amy Wireman | Executive VP & Chief People Officer |
Mr. Alexander Hardy | President, CEO & Director |
Mr. George Eric Davis J.D. | Executive VP, Chief Legal Officer, General Counsel & Secretary |
Dr. C. Greg Guyer Ph.D. | Executive VP & CTO |
Dr. Ganesh Vedantham Ph.D. | Senior Vice President of Technical Development |
Ms. Marni Kottle | Executive VP & Chief Corporate Affairs Officer |
Mr. Brian R. Mueller CPA | Executive VP of Finance, CFO & Principal Accounting Officer |
Dr. Gregory Friberg M.D. | Executive VP and Chief Research & Development Officer |
FAQs
What is Biomarin Pharmaceutical Inc. share price today?
Biomarin Pharmaceutical Inc. share price today is $53.59 as on at the close of the market. Biomarin Pharmaceutical Inc. share today touched a day high of $53.59 and a low of $51.
What is the 52 week high and 52 week low for Biomarin Pharmaceutical Inc. share?
Biomarin Pharmaceutical Inc. share touched a 52 week high of $73.51 on and a 52 week low of $51.1 on . Biomarin Pharmaceutical Inc. stock price today i.e. is closed at $53.59,which is 27.10% down from its 52 week high and 4.87% up from its 52 week low.
What is Biomarin Pharmaceutical Inc.'s market capitalisation today?
Biomarin Pharmaceutical Inc. market capitalisation is $0.01T as on .
How to invest in Biomarin Pharmaceutical Inc. Stock (BMRN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Biomarin Pharmaceutical Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biomarin Pharmaceutical Inc. Shares that will get you 0.0280 shares as per Biomarin Pharmaceutical Inc. share price of $53.59 per share as on November 1, 2025 at 1:29 am IST.
What is the minimum amount required to buy Biomarin Pharmaceutical Inc. Stock (BMRN) from India?
Indian investors can start investing in Biomarin Pharmaceutical Inc. (BMRN) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.65 in Biomarin Pharmaceutical Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biomarin Pharmaceutical Inc. share’s latest price of $53.59 as on November 1, 2025 at 1:29 am IST, you will get 0.1866 shares of Biomarin Pharmaceutical Inc.. Learn more about
fractional shares .
What are the returns that Biomarin Pharmaceutical Inc. has given to Indian investors in the last 5 years?
Biomarin Pharmaceutical Inc. stock has given -30.26% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?